Evoke Pharma Inc - EVOK

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2025 · Q2 2025
Value (USD)
Total reported value ($000)
$2.931M
QoQ value delta ($000)
+$2.331M (+388.5%)
Implied price effect (QoQ)
+91.94%
Shares
Total shares
590,523
QoQ shares delta
+358,501 (+154.51%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (EVOK)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2025)

Top 25 only Full list
Manager Value ($000) Shares % of 13F
MORGAN STANLEY 792 159,358 0.0%
Nantahala Capital Management, LLC 736 148,153 0.03%
Bleichroeder LP 727 146,395 0.14%
National Wealth Management Group, LLC 398 80,130 0.15%
DRW Securities, LLC 117 23,742 0.0%
VANGUARD GROUP INC 93 18,759 0.0%
TWO SIGMA SECURITIES, LLC 51 10,437 0.01%
OSAIC HOLDINGS, INC. 16 3,010 0.0%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 1 272 0.0%
BANK OF AMERICA CORP /DE/ 0 12 0.0%
Tower Research Capital LLC (TRC) 0 40 0.0%
NewEdge Advisors, LLC 0 17 0.0%
SBI Securities Co., Ltd. 0 76 0.0%
BlackRock, Inc. 0 122 0.0%